BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28089633)

  • 1. Definitions of oesophageal cancer.
    Burki TK
    Lancet Oncol; 2017 Feb; 18(2):e71. PubMed ID: 28089633
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutational subgroups for oesophageal adenocarcinoma.
    Burki TK
    Lancet Oncol; 2016 Oct; 17(10):e426. PubMed ID: 27641478
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathology of upper gastrointestinal malignancies.
    Sarbia M; Becker KF; Höfler H
    Semin Oncol; 2004 Aug; 31(4):465-75. PubMed ID: 15297939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma.
    Rosato A; Pivetta M; Parenti A; Iaderosa GA; Zoso A; Milan G; Mandruzzato S; Del Bianco P; Ruol A; Zaninotto G; Zanovello P
    Int J Cancer; 2006 Oct; 119(7):1717-22. PubMed ID: 16671090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using aptamers to elucidate esophageal cancer clinical samples.
    Liu Z; Lu Y; Pu Y; Liu J; Liu B; Yu B; Chen K; Fu T; Yang CJ; Liu H; Tan W
    Sci Rep; 2015 Dec; 5():18516. PubMed ID: 26687301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated genomic characterization of oesophageal carcinoma.
    ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Nature; 2017 Jan; 541(7636):169-175. PubMed ID: 28052061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cancer staging primer: esophagus and esophagogastric junction.
    Rice TW; Blackstone EH; Rusch VW
    J Thorac Cardiovasc Surg; 2010 Mar; 139(3):527-9. PubMed ID: 20176201
    [No Abstract]   [Full Text] [Related]  

  • 8. MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus.
    Hezova R; Kovarikova A; Srovnal J; Zemanova M; Harustiak T; Ehrmann J; Hajduch M; Sachlova M; Svoboda M; Slaby O
    Tumour Biol; 2016 Jun; 37(6):8007-18. PubMed ID: 26711784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of p16 and p16 beta in squamous epithelial carcinomas and adenocarcinomas of the esophagus: differences in regulation dependent on kind of tumor and histology].
    Metzger R; Danenberg K; Hayashi K; Hölscher AH; Danenberg PV
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):491-4. PubMed ID: 14518304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of hypoxia-regulated gene expression in loco-regional gastroesophageal cancer.
    Winther M; Alsner J; Tramm T; Holtved E; Baeksgaard L; Nordsmark M
    Acta Oncol; 2016 May; 55(5):652-5. PubMed ID: 26623712
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential expression of beta mannosidase in human esophageal cancer.
    Sud N; Sharma R; Ray R; Chattopadhyay T; Ralhan R
    Int J Cancer; 2004 Dec; 112(5):905-7. PubMed ID: 15386384
    [No Abstract]   [Full Text] [Related]  

  • 12. [Understanding and appraisal of the new TNM classification for esophageal cancer in the AJCC Cancer Staging Manual (7th edition)].
    Chen LQ
    Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):237-40. PubMed ID: 20450597
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
    Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological analysis of gastro-esophageal diseases by molecular cell techniques.
    Jankowski J; Henderson K; Viaene A; Baert J; Long LQ
    Microsc Res Tech; 1995 Jun; 31(3):184-92. PubMed ID: 7670158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular pathogenesis of carcinoma of the esophagus].
    Giménez AM; Copelli SB; Speroni AH; Meiss RP
    Medicina (B Aires); 2003; 63(3):237-48. PubMed ID: 12876912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective oestrogen receptor antagonists inhibit oesophageal cancer cell proliferation in vitro.
    Al-Khyatt W; Tufarelli C; Khan R; Iftikhar SY
    BMC Cancer; 2018 Feb; 18(1):121. PubMed ID: 29390981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cells in esophageal cancer and response to therapy.
    Harada K; Pool Pizzi M; Baba H; Shanbhag ND; Song S; Ajani JA
    Cancer; 2018 Oct; 124(20):3962-3964. PubMed ID: 30368777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Barrett's carcinoma of the esophagus.
    Hölscher AH; Vallböhmer D; Bollschweiler E
    Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):347-54. PubMed ID: 19131920
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic risk of subsequent esophageal cancer in lymphoma and breast cancer long-term survival patients: a pilot study.
    Boldrin E; Rumiato E; Fassan M; Rugge M; Cagol M; Marino D; Chiarion-Sileni V; Ruol A; Gusella M; Pasini F; Amadori A; Saggioro D
    Pharmacogenomics J; 2016 Jun; 16(3):266-71. PubMed ID: 26054330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancer.
    Winther M; Alsner J; Tramm T; Nordsmark M
    Acta Oncol; 2013 Oct; 52(7):1327-35. PubMed ID: 23957682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.